Fig 1.
Cardiac magnetic resonance in a patient with an inferior ST-elevation myocardial infarction, treated by primary percutaneous coronary intervention.
A. Late gadolinium enhancement (LGE) imaging shows the area of microvascular obstruction (red arrow) in the core of inferior transmural infarction (blue arrow). Contrast fails to penetrate the areas of microvascular obstruction and appears as pseudonormal myocardium. B. T2* mapping shows an area of intra-myocardial hemorrhage (red arrow).
Table 1.
Baseline characteristics of the study population.
Values are mentioned as mean ± SD, median with [interquartile range], or absolute number (with percentage).
Table 2.
Cardiac magnetic resonance parameters.
Values are mentioned as median with [interquartile range], or absolute number (with percentage).
Fig 2.
Interleukin-6 (IL-6), C-reactive protein (CRP), fibrinogen and neutrophils count kinetics according within the first month after STEMI.
Data are expressed as median with interquartile range (IQR). H4: four hours after admission, H12: twelve hours after admission, H24: twenty-four hours after admission, H48: forty-eight hours after admission. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 in comparison with admission level.
Fig 3.
Association between intra-myocardial-hemorrhage (IMH) and inflammatory biomarkers kinetics levels.
IL-6 (A), CRP (B), fibrinogen (C) and neutrophils count (D) kinetics according to the presence of IMH or no IMH on cardiac magnetic imaging 1 week after STEMI. Data are expressed as median with interquartile range (IQR). IL-6: Interleukin-6, CRP: C-reactive protein. *p<0.05, **p<0.01, ***p<0.001.
Fig 4.
Association between microvascular obstruction (MVO) and inflammatory biomarkers kinetics levels.
IL-6 (A), CRP (B), fibrinogen (C) and neutrophils count (D) kinetics according to the presence of MVO or no MVO on cardiac magnetic imaging 1 week after STEMI. Data are expressed as median with interquartile range (IQR). IL-6: Interleukin-6, CRP: C-reactive protein. *p<0.05, **p<0.01.